155 related articles for article (PubMed ID: 35644983)
1. [Impact of co-infection of streptococcus pneumoniae and pneumococcal vaccination on the clinical outcomes of coronavirus disease 19].
Bai YH; Zhang Z; Li SP
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 May; 56(5):659-667. PubMed ID: 35644983
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
[TBL] [Abstract][Full Text] [Related]
3. Lung Pathology of Mutually Exclusive Co-infection with SARS-CoV-2 and Streptococcus pneumoniae.
Tsukamoto T; Nakajima N; Sakurai A; Nakajima M; Sakurai E; Sato Y; Takahashi K; Kanno T; Kataoka M; Katano H; Iwata M; Doi Y; Suzuki T
Emerg Infect Dis; 2021 Mar; 27(3):919-923. PubMed ID: 33443011
[TBL] [Abstract][Full Text] [Related]
4. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
Ingels HA
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
[TBL] [Abstract][Full Text] [Related]
5. Promising Expectations for Pneumococcal Vaccination during COVID-19.
Im H; Ser J; Sim U; Cho H
Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960253
[TBL] [Abstract][Full Text] [Related]
6. Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2.
McIntosh EDG; Feemster K; Rello J
Hum Vaccin Immunother; 2022 Dec; 18(1):1-7. PubMed ID: 34406914
[TBL] [Abstract][Full Text] [Related]
7. The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children.
McNeil JC; Flores AR; Kaplan SL; Hulten KG
Pediatr Infect Dis J; 2021 Aug; 40(8):e313-e316. PubMed ID: 34250979
[TBL] [Abstract][Full Text] [Related]
8. The role of pneumococcal vaccination in reducing cardiovascular risk in cardiac patients: Expert opinion of the Prevention Committee of the Polish Cardiac Society supported by the Polish Vaccinology Society.
Mamcarz A; Wełnicki M; Drożdż J; Grabowski M; Jankowski P; Kuchar E; Leszek P; Mitkowski P; Wysocki J
Kardiol Pol; 2023; 81(10):1038-1046. PubMed ID: 37660388
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of 23-valent pneumococcal polysaccharide vaccine on adult pneumococcal disease].
Li MC; Shao ZJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):1003-1009. PubMed ID: 32907293
[TBL] [Abstract][Full Text] [Related]
10. Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With
Sender V; Hentrich K; Henriques-Normark B
Front Cell Infect Microbiol; 2021; 11():643326. PubMed ID: 33828999
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.
Rodriguez-Nava G; Yanez-Bello MA; Trelles-Garcia DP; Chung CW; Egoryan G; Friedman HJ
Med Sci Monit; 2020 Nov; 26():e928754. PubMed ID: 33188161
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of kaempferol on Streptococcus pneumoniae infection.
Xu L; Fang J; Ou D; Xu J; Deng X; Chi G; Feng H; Wang J
Microbes Infect; 2023; 25(3):105058. PubMed ID: 36216303
[TBL] [Abstract][Full Text] [Related]
13. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
14. Adult pneumococcal vaccination: advances, impact, and unmet needs.
José RJ; Brown JS
Curr Opin Pulm Med; 2017 May; 23(3):225-230. PubMed ID: 28198725
[TBL] [Abstract][Full Text] [Related]
15. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.
Ruiz García Y; Nieto Guevara J; Izurieta P; Vojtek I; Ortega-Barría E; Guzman-Holst A
Expert Rev Vaccines; 2021 Jan; 20(1):45-57. PubMed ID: 33507135
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.
Vila-Corcoles A; Ochoa-Gondar O
Expert Rev Vaccines; 2012 Feb; 11(2):221-36. PubMed ID: 22309670
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Immunization with the Commensal
Shekhar S; Khan R; Schenck K; Petersen FC
Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
[No Abstract] [Full Text] [Related]
19. The prevalence and antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients at Jikei University Hospitals after the implementation of the pneumococcal vaccination program in Japan.
Ando T; Masaki T; Kono M; Nagano Y; Sakamoto K; Tamura T; Abe M; Matsushima M; Nakada K; Matsuura T
J Infect Chemother; 2020 Jul; 26(7):769-774. PubMed ID: 32417263
[TBL] [Abstract][Full Text] [Related]
20. Lethal synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination.
Barman TK; Singh AK; Bonin JL; Nafiz TN; Salmon SL; Metzger DW
JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35482422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
